Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perseus Capital, officially known as Perseus, L.L.C., was a prominent private equity and venture capital firm based in Washington, D.C., with a significant focus on the life sciences and healthcare sectors. Founded by Frank Pearl in 1995, the firm specialized in buyouts, recapitalizations, and growth equity investments in companies ranging from biotechnology to medical technology. Notable healthcare investments included Vanda Pharmaceuticals, Biocon, and various medical device companies. Following the death of its founder in 2012, the firm ceased making new investments and transitioned into a period of portfolio liquidation and inactivity. During its peak, Perseus was recognized for its ability to manage complex investments across diverse industries, including energy and environmental technology alongside its healthcare portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perseus Capital.